Biochips Market (By Type: Protein Chips, Microfluidic Devices and DNA Chips; By Application: Proteomics, Genomics, Drug Discovery & Development, and IVD; By Geography) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024
|発行||Variant Market Research LLP||商品コード||512266|
|出版日||ページ情報||英文 101 Pages
|バイオチップの世界市場：種類（タンパク質チップ、マイクロ流体デバイス、DNAチップ）、用途（プロテオーム解析、ゲノミクス、創薬、体外診断）、地域別 Biochips Market (By Type: Protein Chips, Microfluidic Devices and DNA Chips; By Application: Proteomics, Genomics, Drug Discovery & Development, and IVD; By Geography) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024|
|出版日: 2017年05月23日||ページ情報: 英文 101 Pages||
(By Type: Protein Chips, Microfluidic Devices and DNA Chips; By Application: Proteomics, Genomics, Drug Discovery & Development, and In Vitro Diagnostics (IVD); By Geography: North America, Europe, Asia-Pacific and RoW) Global Scenario, Market Size, Outlook, Trend and Forecast, 2015-2024.
Global Biochips Market is estimated to reach $22 billion by 2024; growing at a CAGR of 15.5% from 2016 to 2024. Continuous research & development and technological advancements have made remarkable progresses in the field of biochips. Components such as silicon, soda glass and fused quartz, among others are used for manufacturing of biochips, which are capable of performing multi biochemical tasks. Biochips are commonly used for diagnosis and prognosis of diseases such as HIV, cancer and heart diseases, and are also used for the detection of bioterrorism agents. Moreover, they are also used for the screening of new drugs which could offer various benefits and evaluate the benefits and risk of pharmaceutical compounds. As they have the capability to exhibit excellent analytical performance and are very cost effective.
Rising prevalence of diseases such as cancer & HIV and expanding application in drug discovery fuels the growth of the biochips market. Moreover, increasing demand for customized medicine, technological advancements and rising generic drug market also boost the growth of the biochips market. Expanding application on cattle disease detection, point-of-care diagnostics and drug lead identification would provide market opportunities in the coming years. However, absence of proper regulations and high cost of instruments may hamper the market growth.
The global biochips market has been segmented into type, application and geography. By type, the market is segmented into microfluidic devices, DNA chips, and protein chips. Furthermore, by applications, it is segmented into proteomics, genomics, in vitro diagnostics (IVD) and drug discovery & development.
Geography segment of the global biochips market includes North America, Europe, Asia-Pacific and Rest of the World (RoW). The U.S., Canada and Mexico are covered under North America wherein Europe covers U.K., Italy, France, Germany and others. Asia-Pacific covers China, India, Japan and others. RoW covers South America, Middle East and Africa.
The key players in the global biochips market include Illumina Inc., Agilent Technologies Inc., Affymetrix Inc., Abbott Laboratories, GE Healthcare, Fluidigm Corporation, Roche Diagnostics, Bio-Rad Laboratories, Cepheid Inc., and Sigma-Aldrich Corporation, among others.